Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
MRM · Nasdaq · United States · Services-Personal Services
In shortMedirom Healthcare Technologies Inc. is profitable, burns cash and carries moderate debt, with revenue growing (+21.5% last year).
Financial health
Weak
Built from five areas over the last five annual reports. Tap an area to see the figures behind it.
| Operating marginShare of each sale left after running the business, before interest and tax. | -0.2% | 16/100 |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | 1.8% | 27/100 |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | 26.0% | 100/100 |
| Return on invested capitalProfit earned on all the capital used (equity and debt). Above 10% usually means a real competitive edge. | -0.6% | 0/100 |
Weight in the score: 25%
| Current ratioShort-term assets divided by short-term debts. Below 1 can mean tight cash. | 0.65× | 0/100 |
|---|---|---|
| Debt / equityDebt compared with the shareholders' stake. Above 2 is heavily indebted. | 1.48× | 29/100 |
| Net debt / EBITDAYears of operating profit needed to repay net debt. Below 2 is comfortable. | 3.86× | 4/100 |
| Interest coverageHow many times operating profit covers interest. Below 2 is risky. | -0.36× | 0/100 |
| Altman Z''Bankruptcy-risk model. Above 2.6 safe, below 1.1 distress. | -0.98 | 0/100 |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | -16.9% | 0/100 |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | -9.43× | 0/100 |
| Years with positive free cash flow (last 5) | 0 of 5 | 0/100 |
Weight in the score: 20%
| Profitable years (last 5) | 3 of 5 | 60/100 |
|---|---|---|
| Years of revenue decline (last 5) | 2 of 5 | 33/100 |
| Revenue growth volatility | 29.5% | 2/100 |
| Operating margin volatility | 9.4% | 23/100 |
Weight in the score: 20%
| Revenue growth, 3-year average | 15.3% | 100/100 |
|---|---|---|
| EPS growth, 3-year average | – | n/a |
Weight in the score: 10%
Fiscal year 2024 · change vs prior year
Annual figures as reported. Hover a bar or point for the exact value.
1 older year available with the 10-year history. Essential plan, from €8.25/month →
The last 5 fiscal years from the company's annual reports.
JPY millions; negative values in parentheses.
| Fiscal year | FY20 | FY21 | FY22 | FY23 | FY24 |
|---|---|---|---|---|---|
| Revenue | 3,342 | 5,410 | 6,954 | 6,828 | 8,299 |
| Cost of revenue | – | – | 5,052 | 5,259 | 6,053 |
| Gross profit | – | – | 1,902 | 1,569 | 2,246 |
| Selling, general & admin | 1,069 | 1,823 | 1,805 | 1,960 | 2,242 |
| Operating income | (746) | (471) | 97 | (392) | (18) |
| Interest expense | 13 | 12 | 9.8 | 37 | 50 |
| Pre-tax income | (627) | (414) | 180 | 21 | 48 |
| Income tax | (88) | 576 | 31 | (94) | (90) |
| Net income | (539) | (991) | 149 | 115 | 149 |
| Diluted EPS | −¥133.97 | −¥203.13 | ¥27.23 | ¥22.34 | ¥28.52 |
| Diluted shares (millions) | 4 | 4.9 | 5.5 | 5.2 | 5.9 |
1 older year available with the 10-year history. Essential plan, from €8.25/month →
−0.98 Distress zone
Estimates bankruptcy risk from working capital, retained earnings, operating profit and equity. Above 2.6 is considered safe, below 1.1 signals distress.
6/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: SEC EDGAR. Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice. How it works
Latest annual report: Dec 31, 2024 · Data updated Oct 21, 2025